Surgical experience with defibrillator implantation using nonthoracotomy leads

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Life-threatening ventricular arrhythmias necessitate advanced treatment options.
• Implantable cardioverter-defibrillators (ICDs) are crucial for managing these conditions.
• Minimally invasive lead systems offer potential advantages in ICD implantation.

Purpose of the Study:

• To evaluate the feasibility and short-term outcomes of nonthoracotomy lead systems for ICD implantation.
• To assess the efficacy and safety of subcutaneous patch and transvenous electrodes in patients with ventricular arrhythmias.

Main Methods:

• A prospective study involving 109 patients with ventricular arrhythmias receiving ICDs.
• Testing of nonthoracotomy lead systems (subcutaneous patch and transvenous electrodes) in 50 patients.
• Comparison with epicardial lead systems in cases of elevated defibrillation thresholds.

Main Results:

• Nonthoracotomy lead systems were successfully implanted in 43 of 50 tested patients (86% success rate).
• No lead system failures (dislocation, fracture, insulation defect) were observed during a mean follow-up of 13 months.
• Cardiovascular survival was 98% at 12 and 18 months; freedom from sudden cardiac death was 100% at 12 months.

Conclusions:

• Nonthoracotomy lead systems represent a feasible and safe option for ICD implantation in selected patients.
• This approach shows promising short-term results, with high survival rates and no lead-related complications.
• Further long-term studies are warranted to confirm the durability and efficacy of these systems.